Phase 2 Trial of Bevacizumab in Combination With Pemetrexed

NCT00227019 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer (NSCLC)
Lung Cancer
Neoplasm Metastasis

Interventions

DRUG: Bevacizumab
DRUG: Pemetrexed
DRUG: Vitamin B12
DRUG: Folate
DRUG: Dexamethasone

Sponsor

Heather Wakelee

Collaborators

[object Object]
[object Object]